SEC Form 4 · accession 0001104659-26-076511
AEON Biopharma, Inc. · AEON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Forth
Director
Period of report
Jun 17, 2026
Accepted (ET)
Jun 22, 2026 · 6:19 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001837607
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Jun 17, 2026 | A | 222,684 | $0.00 | A | 973,231 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents an award of restricted stock units ("RSUs") granted on June 17, 2026 (the "Grant Date"). The RSUs vest in full on the earlier to occur of (i) the one (1) year anniversary of the Grant Date and (ii) the date of the 2027 annual meeting of the Company's stockholders, subject to continued service through the applicable vesting date.